المؤلفون: Cooke SA; Department of Radiation Oncology, Netherlands Cancer Institute (NKI-AVL), Amsterdam, the Netherlands., Belderbos JSA; Department of Radiation Oncology, Netherlands Cancer Institute (NKI-AVL), Amsterdam, the Netherlands. Electronic address: J.belderbos@nki.nl., Reymen B; Department of Radiation Oncology (MAASTRO Clinic), GROW - School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, the Netherlands., Lambrecht M; Department of Oncology, Experimental Radiation Oncology, KU Leuven - University of Leuven, Leuven, Belgium; Department of Radiotherapy-Oncology, University Hospitals Leuven, Gasthuisberg, Belgium., Fredberg Persson G; Department of Oncology, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark; Department of Oncology, Copenhagen University Hospital - Herlev and Gentofte, Copenhagen, Denmark; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark., Faivre-Finn C; Department of Clinical Oncology, University of Manchester, The Christie NHS Foundation Trust, Manchester, UK., Dieleman EMT; Department of Radiation Oncology, Location AMC, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands., van Diessen JNA; Department of Radiation Oncology, Netherlands Cancer Institute (NKI-AVL), Amsterdam, the Netherlands., Sonke JJ; Department of Radiation Oncology, Netherlands Cancer Institute (NKI-AVL), Amsterdam, the Netherlands., de Ruysscher D; Department of Radiation Oncology (MAASTRO Clinic), GROW - School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, the Netherlands.

المصدر: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology [Radiother Oncol] 2024 Jul; Vol. 196, pp. 110312. Date of Electronic Publication: 2024 Apr 24.

نوع المنشور: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase II; Multicenter Study

بيانات الدورية: Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 8407192 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0887 (Electronic) Linking ISSN: 01678140 NLM ISO Abbreviation: Radiother Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Non-Small-Cell Lung*/radiotherapy , Carcinoma, Non-Small-Cell Lung*/pathology , Lung Neoplasms*/radiotherapy , Lung Neoplasms*/pathology , Patient Reported Outcome Measures* , Quality of Life*, Humans ; Male ; Female ; Middle Aged ; Aged ; Neoplasm Staging ; Radiotherapy Dosage ; Chemoradiotherapy/adverse effects ; Positron-Emission Tomography

المؤلفون: Kojima K; Department of General Thoracic Surgery, NHO Kinki Chuo Chest Medical Center, Osaka, Japan k7kensuke@icloud.com., Samejima H; Department of General Thoracic Surgery, NHO Kinki Chuo Chest Medical Center, Osaka, Japan., Okishio K; Clinical Research Center, NHO Kinki Chuo Chest Medical Center, Osaka, Japan.; Department of Thoracic Oncology, NHO Kinki Chuo Chest Medical Center, Osaka, Japan., Tokunaga T; Department of General Thoracic Surgery, NHO Kinki Chuo Chest Medical Center, Osaka, Japan., Yoon H; Department of General Thoracic Surgery, NHO Kinki Chuo Chest Medical Center, Osaka, Japan., Atagi S; Japan Community Health Care Organization, Yamato Koriyama Hospital, Nara, Japan.

المصدر: BMJ open respiratory research [BMJ Open Respir Res] 2024 Sep 26; Vol. 11 (1). Date of Electronic Publication: 2024 Sep 26.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: BMJ Publishing Group Ltd & British Thoracic Society Country of Publication: England NLM ID: 101638061 Publication Model: Electronic Cited Medium: Internet ISSN: 2052-4439 (Electronic) Linking ISSN: 20524439 NLM ISO Abbreviation: BMJ Open Respir Res Subsets: MEDLINE

مواضيع طبية MeSH: Lung Neoplasms*/surgery , Lung Neoplasms*/pathology , Machine Learning* , Carcinoma, Non-Small-Cell Lung*/surgery , Carcinoma, Non-Small-Cell Lung*/pathology , Neoplasm Recurrence, Local* , Lymph Node Excision*/methods, Humans ; Retrospective Studies ; Male ; Female ; Middle Aged ; Aged ; Lymph Nodes/pathology ; Lymphatic Metastasis ; Pneumonectomy/methods

المؤلفون: Duangthim N; Graduate Program in Clinical Biochemistry and Molecular Medicine, Department of Clinical Chemistry, Faculty of Allied Health Sciences, Chulalongkorn University, Bangkok, 10330, Thailand., Lomphithak T; Department of Clinical Chemistry, Faculty of Allied Health Sciences, Chulalongkorn University, Bangkok, 10330, Thailand., Saito-Koyama R; Department of Pathology, Tohoku University School of Medicine, Sendai, Miyagi, 980-8575, Japan.; Department of Pathology, National Hospital Organization, Sendai Medical Center, Sendai, Miyagi, 980-8575, Japan., Miki Y; Department of Pathology, Tohoku University School of Medicine, Sendai, Miyagi, 980-8575, Japan., Inoue C; Department of Pathology, Tohoku University School of Medicine, Sendai, Miyagi, 980-8575, Japan., Sato I; Department of Pathology, Miyagi Prefectural Cancer Center, Natori, Miyagi, 981-1293, Japan., Miyauchi E; Department of Respiratory Medicine, Tohoku University Hospital, Sendai, Miyagi, 980-8575, Japan., Abe J; Department of Thoracic Surgery, Miyagi Cancer Center, Natori, Miyagi, 981-1293, Japan., Sasano H; Department of Pathology, Tohoku University School of Medicine, Sendai, Miyagi, 980-8575, Japan., Jitkaew S; Department of Clinical Chemistry, Faculty of Allied Health Sciences, Chulalongkorn University, Bangkok, 10330, Thailand. Siriporn.Ji@chula.ac.th.; Center of Excellence for Cancer and Inflammation, Department of Clinical Chemistry, Faculty of Allied Health Sciences, Chulalongkorn University, Bangkok, 10330, Thailand. Siriporn.Ji@chula.ac.th.

المصدر: Scientific reports [Sci Rep] 2024 Sep 16; Vol. 14 (1), pp. 21625. Date of Electronic Publication: 2024 Sep 16.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Non-Small-Cell Lung*/drug therapy , Carcinoma, Non-Small-Cell Lung*/pathology , Carcinoma, Non-Small-Cell Lung*/metabolism , Carcinoma, Non-Small-Cell Lung*/immunology , Immune Checkpoint Inhibitors*/therapeutic use , Immune Checkpoint Inhibitors*/pharmacology , Lung Neoplasms*/drug therapy , Lung Neoplasms*/pathology , Lung Neoplasms*/metabolism , Lung Neoplasms*/immunology , Necroptosis*/drug effects , Protein Kinases*/metabolism , Receptor-Interacting Protein Serine-Threonine Kinases*/metabolism , Tumor Microenvironment*, Aged ; Female ; Humans ; Male ; Middle Aged ; CD8-Positive T-Lymphocytes/immunology ; CD8-Positive T-Lymphocytes/metabolism ; Prognosis

المؤلفون: Melosky B; BCCA Vancouver Centre, University of British Columbia, Vancouver, British Columbia, Canada., Vincent MD; London Regional Cancer Centre, University of Western Ontario, London, Ontario, Canada., McGuire AL; Vancouver Coastal Health Research Institute, University of British Colombia, Vancouver, British Columbia, Canada., Brade AM; Trillium Health Partners, University of Toronto, Mississauga, Ontario, Canada., Chu Q; Cross Cancer Institute, University of Alberta, Edmonton, Alberta, Canada., Cheema P; William Osler Health System, University of Toronto, Brampton, Ontario, Canada., Martins I; Kaleidoscope Strategic Inc, Toronto, Ontario, Canada., Spicer JD; McGill University Health Centre, McGill University, Montreal, Quebec, Canada., Snow S; QEII Health Sciences Centre, Dalhousie University, Halifax, Nova Scotia, Canada., Juergens RA; Juravinski Cancer Centre, McMaster University, Hamilton, Ontario, Canada.

المصدر: International journal of cancer [Int J Cancer] 2024 Sep 15; Vol. 155 (6), pp. 963-978. Date of Electronic Publication: 2024 Jun 20.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 0042124 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0215 (Electronic) Linking ISSN: 00207136 NLM ISO Abbreviation: Int J Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Non-Small-Cell Lung*/drug therapy , Carcinoma, Non-Small-Cell Lung*/pathology , Carcinoma, Non-Small-Cell Lung*/genetics , Carcinoma, Non-Small-Cell Lung*/therapy , Lung Neoplasms*/drug therapy , Lung Neoplasms*/pathology , Lung Neoplasms*/therapy , Lung Neoplasms*/genetics, Humans ; Immune Checkpoint Inhibitors/therapeutic use ; Neoplasm Staging ; Molecular Targeted Therapy/methods ; ErbB Receptors/antagonists & inhibitors ; ErbB Receptors/genetics ; Protein Kinase Inhibitors/therapeutic use

المؤلفون: Zhang X; Department of Thoracic Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, People's Republic of China., Xu B; Department of Thoracic Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, People's Republic of China., Ni J; Department of Thoracic Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, People's Republic of China., Xiang Y; Department of Thoracic Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, People's Republic of China., He Z; Department of Thoracic Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, People's Republic of China.

المصدر: International journal of nanomedicine [Int J Nanomedicine] 2024 Sep 14; Vol. 19, pp. 9597-9612. Date of Electronic Publication: 2024 Sep 14 (Print Publication: 2024).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: DOVE Medical Press Country of Publication: New Zealand NLM ID: 101263847 Publication Model: eCollection Cited Medium: Internet ISSN: 1178-2013 (Electronic) Linking ISSN: 11769114 NLM ISO Abbreviation: Int J Nanomedicine Subsets: MEDLINE

مواضيع طبية MeSH: Indoles*/chemistry , Indoles*/pharmacology , Carcinoma, Non-Small-Cell Lung*/therapy , Carcinoma, Non-Small-Cell Lung*/pathology , Carcinoma, Non-Small-Cell Lung*/drug therapy , Doxorubicin*/chemistry , Doxorubicin*/pharmacology , Doxorubicin*/administration & dosage , Doxorubicin*/pharmacokinetics , Polymers*/chemistry , Lung Neoplasms*/therapy , Lung Neoplasms*/pathology , Lung Neoplasms*/drug therapy , Gold*/chemistry , Photothermal Therapy*/methods , Nanospheres*/chemistry, Humans ; Animals ; A549 Cells ; Mice ; Drug Liberation ; Mice, Nude ; Mice, Inbred BALB C ; Particle Size ; Xenograft Model Antitumor Assays ; Combined Modality Therapy/methods ; Cell Survival/drug effects ; Antibiotics, Antineoplastic/chemistry ; Antibiotics, Antineoplastic/pharmacology ; Antibiotics, Antineoplastic/administration & dosage

المؤلفون: Khambholja K; Department of Medical Writing, Catalyst Clinical Research, 2528 Independence Blvd, Suite 100, Wilmington, NC, 28412, USA., Gehani M; Department of Biological Sciences, Birla Institute of Technology and Science, Pilani-Hyderabad Campus, Jawahar Nagar, Shameerpet Mandal, Hyderabad, Telangana, 500078, India. dr.manishgehani@gmail.com., Kothari R; Medical Oncology Department, Narayana Multispecialty Hospital, Opposite Police Station, Near Chakudiya Mahadev, Rakhial, Ahmedabad, Gujarat, 380023, India., Marulkar S; Catalyst Clinical Research, 2528 Independence Blvd, Suite 100, Wilmington, NC, 28412, USA.

المصدر: Systematic reviews [Syst Rev] 2024 Sep 14; Vol. 13 (1), pp. 233. Date of Electronic Publication: 2024 Sep 14.

نوع المنشور: Journal Article; Systematic Review; Meta-Analysis

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 101580575 Publication Model: Electronic Cited Medium: Internet ISSN: 2046-4053 (Electronic) Linking ISSN: 20464053 NLM ISO Abbreviation: Syst Rev Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Non-Small-Cell Lung*/pathology , Carcinoma, Non-Small-Cell Lung*/immunology , Carcinoma, Non-Small-Cell Lung*/mortality , T-Lymphocytes, Regulatory*/immunology , Lung Neoplasms*/pathology , Lung Neoplasms*/immunology , Lung Neoplasms*/mortality, Humans ; Prognosis ; Biomarkers, Tumor ; Neoplasm Staging

المؤلفون: Geng Q; Changzhou Medical Center, Nanjing Medical University, Changzhou, 213003, China.; Department of Oncology, The Affiliated Changzhou No. 2 People's Hospital of Nanjing Medical University, Changzhou, 213003, China., Lu Y; Department of Oncology, The Affiliated Changzhou No. 2 People's Hospital of Nanjing Medical University, Changzhou, 213003, China., Li D; Changzhou Medical Center, Nanjing Medical University, Changzhou, 213003, China.; Department of Oncology, The Affiliated Changzhou No. 2 People's Hospital of Nanjing Medical University, Changzhou, 213003, China., Qin L; Changzhou Medical Center, Nanjing Medical University, Changzhou, 213003, China.; Department of Oncology, The Affiliated Changzhou No. 2 People's Hospital of Nanjing Medical University, Changzhou, 213003, China., Qi C; Changzhou Medical Center, Nanjing Medical University, Changzhou, 213003, China.; Medical Research Center, The Affiliated Changzhou No. 2 People's Hospital of Nanjing Medical University, Changzhou, 213003, China., Pu X; Changzhou Medical Center, Nanjing Medical University, Changzhou, 213003, China.; Department of Oncology, The Affiliated Changzhou No. 2 People's Hospital of Nanjing Medical University, Changzhou, 213003, China., Zhuang Y; Department of Oncology, Changzhou Wujin Hospital of TCM, Changzhou, 213003, China., Zhu Y; Department of Oncology, Jintan Hospital Affiliated to Jiangsu University, Changzhou, Jiangsu, 213200, China., Zha Q; Department of Oncology, Jintan Hospital Affiliated to Jiangsu University, Changzhou, Jiangsu, 213200, China., Wang G; Changzhou Medical Center, Nanjing Medical University, Changzhou, 213003, China.; Department of Oncology, The Affiliated Changzhou No. 2 People's Hospital of Nanjing Medical University, Changzhou, 213003, China., Jiang H; Changzhou Medical Center, Nanjing Medical University, Changzhou, 213003, China. czeyjh@njmu.edu.cn.; Department of Oncology, The Affiliated Changzhou No. 2 People's Hospital of Nanjing Medical University, Changzhou, 213003, China. czeyjh@njmu.edu.cn.

المصدر: BMC immunology [BMC Immunol] 2024 Sep 14; Vol. 25 (1), pp. 60. Date of Electronic Publication: 2024 Sep 14.

نوع المنشور: Journal Article; Clinical Trial

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 100966980 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2172 (Electronic) Linking ISSN: 14712172 NLM ISO Abbreviation: BMC Immunol Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Non-Small-Cell Lung*/drug therapy , Carcinoma, Non-Small-Cell Lung*/immunology , Carcinoma, Non-Small-Cell Lung*/mortality , Lung Neoplasms*/drug therapy , Lung Neoplasms*/immunology , Lung Neoplasms*/pathology , beta-Glucans*/therapeutic use, Humans ; Male ; Female ; Aged ; Middle Aged ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Immune Checkpoint Inhibitors/therapeutic use ; Immune Checkpoint Inhibitors/adverse effects ; Tumor Microenvironment/immunology ; Tumor Microenvironment/drug effects ; Neoplasm Metastasis ; Treatment Outcome

المؤلفون: Zhao Q; Department of Oncology, Renmin Hospital of Wuhan University, Wuhan, 430064, China.; Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University, Shandong Academy of Medical Science, Jinan, 250117, China., Zhong X; Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University, Shandong Academy of Medical Science, Jinan, 250117, China.; Shandong First Medical University, Shandong Academy of Medical Sciences, Jinan, 271016, China., Wang X; Department of Portal Hypertension Intervention, Shandong Public Health Clinical Center, Jinan, 250013, China., Li B; Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University, Shandong Academy of Medical Science, Jinan, 250117, China., Xu Y; Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University, Shandong Academy of Medical Science, Jinan, 250117, China., Yu J; Department of Oncology, Renmin Hospital of Wuhan University, Wuhan, 430064, China. sdyujinming@126.com.; Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University, Shandong Academy of Medical Science, Jinan, 250117, China. sdyujinming@126.com., Wang L; Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University, Shandong Academy of Medical Science, Jinan, 250117, China. wanglinlinatjn@163.com.

المصدر: Scientific reports [Sci Rep] 2024 Sep 13; Vol. 14 (1), pp. 21380. Date of Electronic Publication: 2024 Sep 13.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Non-Small-Cell Lung*/therapy , Carcinoma, Non-Small-Cell Lung*/immunology , Carcinoma, Non-Small-Cell Lung*/pathology , Nomograms* , Lung Neoplasms*/therapy , Lung Neoplasms*/immunology , Lung Neoplasms*/pathology , Lung Neoplasms*/diagnostic imaging , Immunotherapy*/methods, Humans ; Female ; Male ; Middle Aged ; Prognosis ; Aged ; Tomography, X-Ray Computed ; Treatment Outcome ; Tumor Microenvironment/immunology

المؤلفون: Gan X; Department of Pathology, Shenbei New Area, College of Basic Medical Sciences and the First Hospital of China Medical University. No, 77 Puhe Road, Shenyang, 110122, Liaoning Province, People's Republic of China., Feng Y; Department of Pathology, Shenbei New Area, College of Basic Medical Sciences and the First Hospital of China Medical University. No, 77 Puhe Road, Shenyang, 110122, Liaoning Province, People's Republic of China., Liu Y; Department of Pathology, Shenbei New Area, College of Basic Medical Sciences and the First Hospital of China Medical University. No, 77 Puhe Road, Shenyang, 110122, Liaoning Province, People's Republic of China., Lin X; Department of Pathology, Shenbei New Area, College of Basic Medical Sciences and the First Hospital of China Medical University. No, 77 Puhe Road, Shenyang, 110122, Liaoning Province, People's Republic of China., Yu X; Department of Surgical Oncology and Breast Surgery, the First Hospital of China Medical University, Shenyang. No. 155 Nanjing North Street, Heping Area, Shenyang, 110001, Liaoning Province, People's Republic of China. yujinshui@163.com., Rong X; Department of Pathology, the First Hospital of China Medical University. No, 155 Nanjing North Street, Heping Area, Shenyang, 110001, Liaoning Province, People's Republic of China. rxz-168@163.com., Han Q; Department of Pathology, Shenbei New Area, College of Basic Medical Sciences and the First Hospital of China Medical University. No, 77 Puhe Road, Shenyang, 110122, Liaoning Province, People's Republic of China. hanqiangcmu@outlook.com.

المصدر: Cellular & molecular biology letters [Cell Mol Biol Lett] 2024 Sep 12; Vol. 29 (1), pp. 122. Date of Electronic Publication: 2024 Sep 12.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 9607427 Publication Model: Electronic Cited Medium: Internet ISSN: 1689-1392 (Electronic) Linking ISSN: 14258153 NLM ISO Abbreviation: Cell Mol Biol Lett Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Non-Small-Cell Lung*/genetics , Carcinoma, Non-Small-Cell Lung*/metabolism , Carcinoma, Non-Small-Cell Lung*/pathology , Hippo Signaling Pathway* , Lung Neoplasms*/genetics , Lung Neoplasms*/metabolism , Lung Neoplasms*/pathology , Protein Serine-Threonine Kinases*/metabolism , Protein Serine-Threonine Kinases*/genetics , Sirtuin 1*/metabolism , Sirtuin 1*/genetics , Wnt Signaling Pathway*/genetics , Protein Inhibitors of Activated STAT*/genetics , Protein Inhibitors of Activated STAT*/metabolism, Animals ; Female ; Humans ; Male ; Mice ; Middle Aged ; A549 Cells ; Cell Line, Tumor ; Cell Movement/genetics ; Cell Proliferation/genetics ; Gene Expression Regulation, Neoplastic ; Mice, Nude ; Transcription Factors/metabolism ; Transcription Factors/genetics

المؤلفون: Xitlally PN; Personalized Medicine Laboratory, Instituto Nacional de Cancerología (INCan), Mexico City, 14080, Mexico., Alejandro AS; Pathology department, Instituto Nacional de Cancerología (INCan), Mexico City, 14080, Mexico., Norma HP; Personalized Medicine Laboratory, Instituto Nacional de Cancerología (INCan), Mexico City, 14080, Mexico. nhernandezp@incan.edu.mx., Mario OM; Personalized Medicine Laboratory, Instituto Nacional de Cancerología (INCan), Mexico City, 14080, Mexico., Enrique CP; Thoracic Oncology Unit, Instituto Nacional de Cancerología (INCan), Mexico City, 14080, Mexico.; Personalized Medicine Laboratory, Instituto Nacional de Cancerología (INCan), Mexico City, 14080, Mexico., Cesar CR; Personalized Medicine Laboratory, Instituto Nacional de Cancerología (INCan), Mexico City, 14080, Mexico., José LL; Personalized Medicine Laboratory, Instituto Nacional de Cancerología (INCan), Mexico City, 14080, Mexico., Pedro BB; Personalized Medicine Laboratory, Instituto Nacional de Cancerología (INCan), Mexico City, 14080, Mexico., Juan-Manuel HM; CONAHCYT-Instituto Nacional de Cancerología, Mexico City, Mexico., Oscar A; Thoracic Oncology Unit, Instituto Nacional de Cancerología (INCan), Mexico City, 14080, Mexico. ogar@unam.mx.; Personalized Medicine Laboratory, Instituto Nacional de Cancerología (INCan), Mexico City, 14080, Mexico. ogar@unam.mx.

المصدر: Journal of translational medicine [J Transl Med] 2024 Sep 12; Vol. 22 (1), pp. 841. Date of Electronic Publication: 2024 Sep 12.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 101190741 Publication Model: Electronic Cited Medium: Internet ISSN: 1479-5876 (Electronic) Linking ISSN: 14795876 NLM ISO Abbreviation: J Transl Med Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Non-Small-Cell Lung*/genetics , Carcinoma, Non-Small-Cell Lung*/pathology , Carcinoma, Non-Small-Cell Lung*/metabolism , Lung Neoplasms*/genetics , Lung Neoplasms*/pathology , Lung Neoplasms*/metabolism , Receptors, Virus*/genetics , Receptors, Virus*/metabolism, Humans ; Male ; Female ; Middle Aged ; Prognosis ; Aged ; Mutation/genetics ; Adult ; ErbB Receptors/metabolism ; ErbB Receptors/genetics ; Aged, 80 and over ; ROC Curve